InsidersTradesSigma
Total declarations
Company
▲ Purchases (1 ops.)
▼ Sales (0 ops.)
Insider track record
Board DirectorDisclosed buys
1
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Discover the complete record of transactions filed by Silver Gabrielle Alison, Director. Officer active across 1 company, notably Opiant Pharmaceuticals, INC.. Cumulatively, 7 reports have been logged. Split: 1 buy · 0 sell. Total volume traded: €32k. Activity tracked since 13 May 2021. The latest transaction was disclosed on 2 March 2023 (Disposition). Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations7 total
21,343 shares@ US$20.0091.4% of flowCommon StockSEC:0001385508-23-000077:0
2,000 shares0Common StockSEC:0001385508-22-000082:0
2,500 shares@ US$13.28884.0% of flowCommon StockSEC:0001385508-22-000062:0
Ideal exit: 10 Feb 2023 (T+270)
2,000 shares0Common StockSEC:0001385508-21-000085
2,000 shares0Common StockSEC:0001385508-21-000085:0
365 shares@ US$10.008.0% of flowCommon StockSEC:0001385508-21-000071
365 shares@ US$10.008.0% of flowCommon StockSEC:0001385508-21-000071:0
7 of 7 declarations
About Silver Gabrielle Alison
Gabrielle Alison Silver is a Director at Opiant Pharmaceuticals, Inc. She actively participates in board discussions, bringing her expertise in the pharmaceutical field. Gabrielle contributes to the company's strategy and oversight of product development initiatives.
